Member Info for oj17

charts meaningless when war is started - its all about sentiment not lines on a graph

its not a ramp - i clearly said in prevous posts that i had no money in EVRAZ it is just a better bet than SNG, I was hoping that the experts who laughed at me last week when I said that SNG may run out of money after the FAIL rns might apoligise - but no they are suspiciosly silent.

YOU need to target the rampers of a failed SNG who liked the smile of RM at the right point of an interview....not me

i only mention EVRAZ because on the risk scale both SNG and EVRAZ are off the scale - but IMHO EVRAZ will actually make you money at this point

ive never had money in EVRAZ - but i think better growth and superb dividend than SNG

PS...down 30 PERCENT today...

i might buy back in at 10p but as i mentioned about 10 days ago this company will run out of money. in the latest RNS they said they had 25 million - but what do they owe to suppliers for the ramping up of manufacturing ( that is now not needed), huge salaries of marketing ( that was never needed!) Directors salaries for doing F all!.

Forget it guys this is a share to buy at 10 p and forget

Seriously - you have been on a different planet.

The trial FAILED
The share price is down 90 PERCENT
Covid is OVER
spend your money on EVRAZ it has a better future

As announced on 21st February, we are reviewing the study's full dataset to better understand the detailed results and implications for development of SNG001 and will provide an update as soon as possible as in accordance with our stock market listing rules. While the overall study outcome is disappointing, we have observed an encouraging trend in prevention of progression to severe disease and death (36. 3% in the per protocol population), which we and our clinical advisors strongly believe merits further investigation in a large platform trial. We are exploring trials that might be suitable.

meaning - Rights Issue!!

i think it just says that they wernt as confident of the outcome as some folks here. They hedged their bets.. All the nonsense on here about RM having a little knowing smile at certain points on certain interviews was just BS... he knew it could go either way as did all the other directors who sold a big chunk of their options.

its only fact - not smoke and mirrors which is what most people post...

bought for a penny - sold for 1.40 on same day - of course they knew something

Director/Date/Type Amount Price (Pence) Value (£) Amount % Additional Info
Mr. Richard James Marsden
19/08/2021 | Sale of Option
296,959 140.00 415,743.00 995,771 0.49
Mr. Richard James Marsden
19/08/2021 | Exercise of Option
538,063 1.00 5,381.00 1,292,730 0.65
Dr. Phillip David Monk
19/08/2021 | Sale of Option
220,878 140.00 309,229.00 423,934 0.21
Dr. Phillip David Monk
19/08/2021 | Exercise of Option
400,212 1.00 4,002.00 644,812 0.32
Mr. John Christopher Ward
19/08/2021 | Sale of Option
269,963 140.00 377,948.00 734,092 0.36
Mr. John Christopher Ward
19/08/2021 | Exercise of Option
489,148 1.00 4,891.00 1,004,055

RM and another senior director sold a huge chunk of shares last year - what did that tell you

Im very tempted to move to cash monday -if not too late. There is very little loss to the upside if no invasion happens. But massive downside id it does.. The downside short lived but i think massive opportunity to sell and buy about 30 - 40 percent cheaper

but the dividend wasnt increased!

Does anybody think the lack of divvy increase is in some way designed to hold the share price down whilst the company share buy back proceeds - 17.5 Million shares bought and cancelled today.... keeping price down means cancelling more shares. Then the divvy will increase when share buy back completed.

No Divvy increase....

37 Million spent in 6 months up to 30 June 21, 46M cash left on 30 June. Assume 0 income. Assume slightly more spent in second 6 months of year say - 40 Million. Doesnt leave a lot until end of Feb 2022.

yeh did my research - thats why i said end of Feb - was looking for other opinions. Cash is going to be a problem soon and no point to stick head in sand about it

When do we think SNG will run out of cash without deal/buyout/rights issue? I think end of Feb. looking at last results and cash burn. Any other opinion?

Synairgen - is NOT worth 10 billion - thats a pipe dream. It could be back to 5p a share in next few months if not worse - they are just about to run out of cash and need to raise funds again

Ambulance chasers.........